Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. (AUPH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · AUPH · as of Mar 31, 2025
Ownership Breakdown
227
Institutional Holders
▲ 9 vs Q4
$504.13M
Total Inst. Value
▼ $21.22M vs Q4
128.60M
Shares Outstanding
freeFloat 98.16%
62.69M
13F Shares Held
▲ 4.19M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
AUPH largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
TANG CAPITAL MANAGEMENT LLC pharmaceutical preparations | 10.03M | 7.22% | 7.22% | $80.64B | May 15, 2025 | ▲ 1.60M |
BLACKROCK, INC. pharmaceutical preparations | 8.76M | 6.31% | 6.31% | $70.43B | May 2, 2025 | ▼ 192.3K |
ARMISTICE CAPITAL, LLC pharmaceutical preparations | 5.00M | 3.60% | 3.60% | $40.20B | May 15, 2025 | ▼ 1.40M |
NEA MANAGEMENT COMPANY, LLC pharmaceutical preparations | 3.97M | 2.86% | 2.86% | $31.92B | May 14, 2025 | — held |
STATE STREET CORP pharmaceutical preparations | 2.85M | 2.05% | 2.05% | $22.92B | May 15, 2025 | ▼ 66.9K |
MORGAN STANLEY pharmaceutical preparations | 2.37M | 1.70% | 1.70% | $19.04B | May 15, 2025 | ▲ 722.6K |
VANGUARD GROUP INC pharmaceutical preparations | 1.97M | 1.42% | 1.42% | $15.85B | May 9, 2025 | ▲ 241.9K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 1.73M | 1.25% | 1.25% | $13.94B | May 13, 2025 | ▼ 30.1K |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP pharmaceutical preparations | 1.64M | 1.18% | 1.18% | $13.19B | May 14, 2025 | ▲ 564.5K |
GOLDMAN SACHS GROUP INC pharmaceutical preparations | 1.63M | 1.17% | 1.17% | $13.12B | Jun 27, 2025 | ▼ 120.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
26
Increased
+6.86M shares6
New Positions
first time holders17
Decreased
−3.11M shares0
Sold Out
fully exitedNet shares change (top 50)
+3.74M
+6.86M / −3.11M
Net new holders
+15
6 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
AUPH insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
11
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
TANG KEVIN Chief Executive Officer | Jun 2, 2026 | Purchase | 206,005 | $15.28 | $3.15M | 13.04M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | Jun 1, 2026 | Purchase | 99 | $15.34 | $1.5K | 12.84M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | Jun 1, 2026 | Purchase | 343,521 | $15.28 | $5.25M | 12.84M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | May 29, 2026 | Purchase | 262,682 | $15.31 | $4.02M | 12.49M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | May 29, 2026 | Purchase | 2,299 | $15.35 | $35.3K | 12.23M | Form 4 ↗ |
TANG KEVIN Chief Executive Officer | Jun 2, 2026 | J-Other | 10,000 | $15.00 | $150.0K | 10.0K | Form 4 ↗ |
Robertson Stephen P. Chief Legal Officer | May 18, 2026 | Award | 115,541 | — | — | 621.4K | Form 4 ↗ |
Hearne Michael S Chief Financial Officer | May 18, 2026 | Award | 116,144 | — | — | 116.1K | Form 4 ↗ |
Hearne Michael S Chief Financial Officer | May 18, 2026 | Award | 70,230 | $15.28 | $1.07M | 70.2K | Form 4 ↗ |
Cole Ryan Chief Operating Officer | May 18, 2026 | Award | 116,144 | — | — | 116.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Aurinia Pharmaceuticals Inc. (AUPH) is primarily owned by institutional investors, who hold approximately 48.8% of total shares outstanding. Company insiders own approximately 1.84%, while retail and public investors account for the remaining 49.41%.
The largest institutional shareholder of Aurinia Pharmaceuticals Inc. is TANG CAPITAL MANAGEMENT LLC, holding approximately 10.03 million shares — equal to 7.22% of outstanding shares — as of March 31, 2025.
A total of 227 institutional investors currently hold AUPH stock, with a combined institutional value of approximately $504,134,953 as of the most recent 13F filing period.
Frequently asked questions
AUPH ownershipAurinia Pharmaceuticals Inc. (AUPH) is primarily owned by institutional investors, who hold approximately 48.8% of shares. The largest shareholder is TANG CAPITAL MANAGEMENT LLC with a 7.22% stake. Company insiders hold 1.84%. Data sourced from SEC Form 13F as of March 31, 2025.